Nobivac Forcat

Land: New Zealand

Sprog: engelsk

Kilde: Ministry for Primary Industries

Aktiv bestanddel:

feline chlamydia psittaci strain baker; feline calici virus (attenuated); feline panleucopenia virus (attenuated); feline rhinotracheitis virus (attenuated)

Tilgængelig fra:

Schering-Plough Animal Health Ltd

INN (International Name):

feline panleucopenia virus (attenuated), feline rhinotracheitis virus (attenuated), feline chlamydia psittaci strain baker, feli

Sammensætning:

feline chlamydia psittaci strain baker 0 vaccine; feline calici virus (attenuated) 0 vaccine; feline panleucopenia virus (attenuated) 0 vaccine; feline rhinotracheitis virus (attenuated) 0 vaccine

Terapeutisk område:

Vaccine

Autorisation status:

ACVM Registered

Autorisation dato:

2001-10-23

Produktets egenskaber

RESTRICTED VETERINARY MEDICINE
Live combined freeze-dried feline herpes virus, calicivirus and
panleucopaenia virus and _Chlamydophila felis_ vaccine.
Store between +2°C and +8°C.
Once reconstituted use within 30 minutes.
ACVM No. A8299
Nobivac
®
Forcat
Nobivac
®
Forcat
Batch:
Exp:
1 dose
143559 R2
PSB020874 03 R2
50x22mm
PMS 258+206+black
Batch:
Exp:
Lot:
Exp:
Read entire leaflet before use.
Store between 2°C and 8°C.
Once reconstituted use within 30 min.
PSB010881 05 R1 45x75mm black
146363 R1
RESTRICTED VETERINARY MEDICINE
Keep out of reach of children
FOR ANIMAL TREATMENT ONLY
Nobivac
®
Forcat
Live Attenuated Vaccine for Cats
A live freeze-dried vaccine, containing:
- Live attenuated feline calicivirus (strain F9)
- Live attenuated feline herpes virus type 1 (rhinotracheitis) (strain
G2620A)
- Live attenuated feline panleucopaenia virus (strain MW-1)
- Live attenuated _Chlamydophila felis_ (strain Baker)
It is presented as a freeze-dried pellet, each pack contains 5 single
dose vials. Pack also
contains 5 corresponding 1mL vials of diluent for reconstitution prior
to injection.
INDICATION
For active immunisation of cats from the age of 8-9 weeks onwards to:
-
reduce clinical signs caused by an infection with feline calicivirus
(FCV) and feline herpes
virus type 1 (FHV)
-
to reduce the severity of the clinical signs caused by infection with
_Chamydophila felis_
-
to reduce replication of feline calicivirus (FCV)
-
and to prevent clinical signs, leucopenia and shedding caused by
infection with feline
panleucopaenia virus (FPLV)
The onset of immunity is 4 weeks for FCV & FHV, and 3 weeks for FPLV
and _C. felis_ following
first vaccination.
The duration of immunity is 1 year for the FCV, FHV and _C. felis_
components and 3 years for
the FPLV component.
DOSAGE AND ADMINISTRATION
Initial programme
Two doses injected subcutaneously, at an interval of 3-4 weeks are
required. The first
vaccination is given from the age of 8-9 weeks and the second
vaccination from the age of
12 weeks. If earlier vaccination is d